abrdn Life Sciences Investors (HQL) vs Value Line (VALU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Value Line (VALU) has outperformed abrdn Life Sciences Investors (HQL) over the past year, gaining 14.1% versus a gain of 11.2%. Over five years, VALU leads with a +37.2% price change compared with -15.0% for HQL. On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 20.9x for Value Line).
abrdn Life Sciences Investors offers the higher dividend yield (11.02% vs 3.06%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQL | VALU |
|---|---|---|
| Share price | $17.33 | $44.05 |
| Market cap | — | $413.28M |
| 1-day change | -1.34% | -0.88% |
| YTD return | +4.65% | +15.64% |
| 1-year return | +11.21% | +14.09% |
| 5-year return | -15.00% | +37.16% |
| P/E ratio (TTM) | 2.61 | 20.88 |
| EPS (TTM) | $6.64 | $2.11 |
| Dividend yield | 11.02% | 3.06% |
| Annual dividend | $1.91 | $1.35 |
| 52-week high | $22.67 | $45.20 |
| 52-week low | $15.66 | $32.00 |
| Distance from 52-week high | -23.58% | -2.54% |
| Average volume | 147.31K | 3.55K |
| Shares outstanding | — | 9.38M |
| Employees | — | 106 |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Value Line trades at a higher earnings multiple (20.9x vs 2.6x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (11.02% vs 3.06%).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
About Value Line
VALU stock →Value Line, Inc. engages in the production and sale of investment periodicals and related publications.
Finance · Investment Managers · 106 employees
HQL vs VALU FAQ
Which stock has performed better over the past year, HQL or VALU?
VALU returned +14.09% over the past 12 months, compared with +11.21% for HQL (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, HQL or VALU?
HQL has the lower trailing P/E at 2.6, versus 20.9 for VALU. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or Value Line?
abrdn Life Sciences Investors has the higher yield at 11.02%, compared with 3.06% for Value Line.
Are abrdn Life Sciences Investors and Value Line in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.